| PHRCX | VGSNX | PHRCX / VGSNX | |
| Total Expense Ratio | 1.99 | 0.11 | 1,809% |
| Annual Report Gross Expense Ratio | 2.08 | 0.11 | 1,891% |
| Fund Existence | 22 years | 22 years | - |
| Gain YTD | -0.031 | 3.304 | -1% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 344M | 64B | 1% |
| Annual Yield % from dividends | 1.16 | 3.98 | 29% |
| Returns for 1 year | -10.60 | -1.77 | 598% |
| Returns for 3 years | -7.15 | 19.56 | -37% |
| Returns for 5 years | -5.45 | 26.98 | -20% |
| Returns for 10 years | -48.22 | 63.95 | -75% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VVJEX | 11.78 | N/A | N/A |
| Voya VACS Series MCV Fund | |||
| GVIRX | 18.84 | -0.22 | -1.15% |
| Goldman Sachs US Eq Div and Premium Inv | |||
| GTDIX | 40.58 | -0.48 | -1.17% |
| Invesco Emerging Markets ex-China R5 | |||
| RNWGX | 97.54 | -1.26 | -1.28% |
| American Funds New World R6 | |||
| RMDAX | 5.36 | -0.16 | -2.90% |
| Virtus Silvant Mid-Cap Growth A | |||